September 7, 2018 / 6:10 AM / 2 months ago

BRIEF-Quantum Genomics Completes Patient Recruitment In Phase IIB Hypertension Study

Sept 7 (Reuters) - QUANTUM GENOMICS:

* SAID ON THURSDAY IT COMPLETED PATIENT RECRUITMENT MORE THAN SIX MONTHS AHEAD OF INITIAL SCHEDULE IN ITS PHASE IIB HYPERTENSION STUDY

* EXPECTS TO PRESENT RESULTS BY MID-NOVEMBER 2018

* NEW-HOPE RESULTS WILL REPRESENT A MAJOR MILESTONE IN CLINICAL DEVELOPMENT OF FIRIBASTAT AND MAY SUPPORT DESIGN OF FUTURE PHASE III TRIAL

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below